BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 21813584)

  • 1. Altruism among participants in cancer clinical trials.
    Truong TH; Weeks JC; Cook EF; Joffe S
    Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
    Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
    Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivation for participation in clinical trials of drugs for the treatment of asthma, seasonal allergic rhinitis, and perennial nonallergic rhinitis.
    Aby JS; Pheley AM; Steinberg P
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):348-54. PubMed ID: 8612117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
    Schutta KM; Burnett CB
    Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying motivations and barriers to patient participation in clinical trials.
    Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
    J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of informed consent among parents of children in cancer clinical trials.
    Truong TH; Weeks JC; Cook EF; Joffe S
    Pediatr Blood Cancer; 2011 Dec; 57(6):998-1004. PubMed ID: 21280199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' preferences about participation in clinical trials studying complementary and alternative medicine.
    Prasad K; Wahner-Roedler D; Cha S; Sood A
    Altern Ther Health Med; 2011; 17(6):36-42. PubMed ID: 22314718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participating in research: exploring participation and engagement in a study of self-management for people with chronic obstructive pulmonary disease.
    Willis KF; Robinson A; Wood-Baker R; Turner P; Walters EH
    Qual Health Res; 2011 Sep; 21(9):1273-82. PubMed ID: 21474655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personal benefit, or benefiting others? Deciding whether to take part in clinical trials.
    Locock L; Smith L
    Clin Trials; 2011 Feb; 8(1):85-93. PubMed ID: 21163854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experiences of children enrolled in pediatric oncology research: implications for assent.
    Unguru Y; Sill AM; Kamani N
    Pediatrics; 2010 Apr; 125(4):e876-83. PubMed ID: 20351001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials.
    Zhang J; Zhang H; Yu C; Li J; Jiang Y
    Contemp Clin Trials; 2011 Sep; 32(5):649-53. PubMed ID: 21570486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation.
    Guedj M; Ballester S; Kamar N; Rostaing L; Donckier V; Goldman M; Cambon-Thomsen A
    Clin Transplant; 2013; 27(5):724-31. PubMed ID: 24033357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure.
    Bergenmar M; Johansson H; Wilking N
    Clin Trials; 2011 Feb; 8(1):77-84. PubMed ID: 21109583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
    Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
    Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participants' perceptions of motivation, randomisation and withdrawal in a randomised controlled trial of interventions for prevention of depression.
    Grant JB; Mackinnon AJ; Christensen H; Walker J
    J Med Ethics; 2009 Dec; 35(12):768-73. PubMed ID: 19948934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altruistic discourse in the informed consent process for childhood cancer clinical trials.
    Simon C; Eder M; Kodish E; Siminoff L
    Am J Bioeth; 2006; 6(5):40-7. PubMed ID: 16997825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring cancer clinical trial understanding.
    Miller JD; Kotowski MR; Comis RL; Smith SW; Silk KJ; Colaizzi DD; Kimmel LG
    Health Commun; 2011 Jan; 26(1):82-93. PubMed ID: 21218302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.